Exosomes: the new frontier in wound healing and scar therapy?

By Ana Espino | Published on March 23, 2026 | 3 min read
 

Scars, particularly hypertrophic scars and keloids, pose a major medical problem, impacting the quality of life of many patients following injuries or surgical procedures. While wound healing is effective in some individuals, it can be complicated by poor healing and excessive scar tissue formation. Existing treatments, such as skin grafts or corticosteroid therapies, have limitations in terms of effectiveness and safety.   Recent research has turned towards exosomes derived from human placental mesenchymal stem cells (hpMSC-exosomes), which offer new therapeutic potential in the field of regenerative medicine. These exosomes, small extracellular vesicles involved in intercellular communication, possess regenerative and anti-inflammatory properties. This study, published in Aesthetic Surgery Journal, aimed to conduct a systematic review and meta-analysis of preclinical and clinical data on the use of hpMSC-exosomes for wound healing and scar reduction.   Exosomes: the key to faster healing?   The study included 738 patients treated with hpMSC-derived exosomes over a 7-year period, covering various aesthetic and reconstructive indications. The analysis included preclinical studies, early-phase clinical trials, as well as case series and observational studies. Data were extracted from scientific databases such as PubMed, Cochrane Library, EMBASE, and Web of Science.   The meta-analysis of 21 preclinical studies (involving 323 animals) showed significant results. HpMSC-exosomes promoted wound healing by stimulating neovascularization, reducing inflammation, and enhancing collagen production. These exosomes also demonstrated an immunomodulatory effect, fostering a beneficial anti-inflammatory response.   In clinical studies, the results were also promising, though limited by the small number of human trials. One clinical study showed improvement in the appearance of acne scars in patients who received exosomes combined with CO2 laser treatment, with reduced post-treatment erythema and a shorter recovery time. Additionally, cases of accelerated healing of traumatic wounds were observed, with notable improvements in pain and swelling in patients.   Exosomes: a revolution for wound healing?   Hypertrophic scars and keloids represent a complex pathology to treat, and existing treatments are often insufficient. The objective of this study was to determine if exosomes derived from human placental mesenchymal stem cells could offer an effective solution for improving wound healing and treating scars.   The results show significant potential for hpMSC-exosomes to accelerate wound healing and reduce scar formation, particularly due to their anti-inflammatory and regenerative effects. However, large-scale clinical studies are needed to confirm their efficacy and safety in a clinical setting. The main challenges to overcome include the standardization of exosome manufacturing processes and obtaining FDA approval, which requires overcoming regulatory and technical hurdles.   Despite these challenges, this approach offers promising perspectives for the treatment of chronic wounds and scars and paves the way for future research on other applications of exosomes in regenerative medic

Read next: Severely burned patients: where does tissue reconstruction stand?

About the author – Ana Espino
PhD in Immunology, specialized in Virology  
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.